The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study

NCT02267525 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

233

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroparesis

Interventions

DRUG: Velusetrag
DRUG: Placebo

Sponsor

Theravance Biopharma

Collaborators

[object Object]